2013
DOI: 10.1007/7355_2013_20
|View full text |Cite
|
Sign up to set email alerts
|

The Blood–Brain Barrier: An Introduction to Its Structure and Function

Abstract: The blood-brain barrier (BBB) formed by the brains microvascular system is impermeable for most therapeutically used compounds and overcoming this barrier remains to be one of the big challenges in modern medicine. It is composed of highly specialized endothelial cells, which are surrounded by pericytes and a basal membrane. Together with nearby astrocytes and neurons they constitute the so-called neurovascular unit, which restricts substance transfer from blood to brain and vice versa and maintains the cerebr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 177 publications
(163 reference statements)
0
1
0
Order By: Relevance
“…For instance, orally administered liposomes are very sensitive to gastrointestinal conditions, i.e., gastric acid, bile salts, and lipases [34], while the intravenous delivery of liposomes is associated with serum protein adsorption, which results in liposome removal by RES, mainly in the liver [35]. When brain is the target of liposomal drug delivery systems, the situation becomes more challenging due to the BBB, formed by the brain microvascular system [36], which separates the bloodstream from the CNS, as well as the P-glycoprotein, the most important efflux transporter associated to the failure of various therapies applied to treat CNS diseases [37]. In addition, nanosized liposomes (<100 nm) tend to attract each other to reduce their surface tension, which causes loss of payload or unwanted mixing [38,39].…”
Section: Classical Liposomesmentioning
confidence: 99%
“…For instance, orally administered liposomes are very sensitive to gastrointestinal conditions, i.e., gastric acid, bile salts, and lipases [34], while the intravenous delivery of liposomes is associated with serum protein adsorption, which results in liposome removal by RES, mainly in the liver [35]. When brain is the target of liposomal drug delivery systems, the situation becomes more challenging due to the BBB, formed by the brain microvascular system [36], which separates the bloodstream from the CNS, as well as the P-glycoprotein, the most important efflux transporter associated to the failure of various therapies applied to treat CNS diseases [37]. In addition, nanosized liposomes (<100 nm) tend to attract each other to reduce their surface tension, which causes loss of payload or unwanted mixing [38,39].…”
Section: Classical Liposomesmentioning
confidence: 99%